Nammi Therapeutics
About:
Nammi Therapeutics is an immunotherapy company that develops nano-enabled chemo-immunotherapy for the treatment of cancer.
Website: https://www.nammirx.com
Top Investors: Myeloma Investment Fund
Description:
Total Funding Amount:
$9.2M
Estimated Revenue Range:
Less than $1M
Headquarters Location:
Los Angeles, California, United States
Founded Date:
2018-01-01
Contact Email:
info(AT)nammirx.com
Founders:
David Stover
Number of Employees:
1-10
Last Funding Date:
2024-08-06
IPO Status:
Private
Industries:
© 2025 bioDAO.ai